Alphatec Holdings, Inc. (ATEC)
USD 10.01
(-1.96%)
USD 10.01
(-1.96%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 320.7 Million USD | 3.07% |
| 2022 | 311.16 Million USD | 270.32% |
| 2021 | -182.69 Million USD | -77.93% |
| 2020 | -102.68 Million USD | -126.62% |
| 2019 | -45.31 Million USD | -75.77% |
| 2018 | -25.77 Million USD | -238.54% |
| 2017 | 18.6 Million USD | 212.91% |
| 2016 | -16.48 Million USD | -123.93% |
| 2015 | 68.87 Million USD | 690.75% |
| 2014 | -11.65 Million USD | 29.0% |
| 2013 | -16.42 Million USD | 20.06% |
| 2012 | -20.54 Million USD | -26.25% |
| 2011 | -16.27 Million USD | 24.18% |
| 2010 | -21.46 Million USD | -538.5% |
| 2009 | -3.36 Million USD | 79.26% |
| 2008 | -16.2 Million USD | 15.29% |
| 2007 | -19.13 Million USD | -122.23% |
| 2006 | -8.6 Million USD | -218.73% |
| 2005 | 7.25 Million USD | 81.91% |
| 2004 | 3.98 Million USD | 0.0% |
| 2002 | 187 Thousand USD | 119.13% |
| 2001 | -977.3 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 455.69 Million USD | 14.88% |
| 2024 Q1 | 396.66 Million USD | 23.68% |
| 2024 Q3 | 482.87 Million USD | 5.97% |
| 2023 FY | 320.7 Million USD | 3.07% |
| 2023 Q4 | 320.7 Million USD | -22.8% |
| 2023 Q3 | 415.43 Million USD | 7.45% |
| 2023 Q2 | 386.63 Million USD | 503.45% |
| 2023 Q1 | -95.83 Million USD | -130.8% |
| 2022 Q3 | 287.24 Million USD | 14.12% |
| 2022 Q2 | 251.69 Million USD | 23.03% |
| 2022 Q4 | 311.16 Million USD | 8.33% |
| 2022 FY | 311.16 Million USD | 270.32% |
| 2022 Q1 | 204.58 Million USD | 211.98% |
| 2021 FY | -182.69 Million USD | -77.93% |
| 2021 Q1 | -124.94 Million USD | -21.68% |
| 2021 Q2 | 18.38 Million USD | 114.72% |
| 2021 Q3 | 132.03 Million USD | 618.13% |
| 2021 Q4 | -182.69 Million USD | -238.37% |
| 2020 Q4 | -102.68 Million USD | -293.66% |
| 2020 Q3 | 53.02 Million USD | 43.68% |
| 2020 FY | -102.68 Million USD | -126.62% |
| 2020 Q1 | 28.39 Million USD | 162.67% |
| 2020 Q2 | 36.9 Million USD | 29.95% |
| 2019 Q2 | -17.11 Million USD | -157.67% |
| 2019 FY | -45.31 Million USD | -75.77% |
| 2019 Q4 | -45.31 Million USD | 18.72% |
| 2019 Q3 | -55.74 Million USD | -225.78% |
| 2019 Q1 | 29.66 Million USD | 215.09% |
| 2018 Q3 | 5.36 Million USD | 217.44% |
| 2018 Q2 | -4.56 Million USD | 25.05% |
| 2018 Q1 | -6.08 Million USD | -132.72% |
| 2018 Q4 | -25.77 Million USD | -580.93% |
| 2018 FY | -25.77 Million USD | -238.54% |
| 2017 Q1 | 17.14 Million USD | 204.05% |
| 2017 FY | 18.6 Million USD | 212.91% |
| 2017 Q4 | 18.6 Million USD | -25.06% |
| 2017 Q3 | 24.82 Million USD | 16.0% |
| 2017 Q2 | 21.4 Million USD | 24.82% |
| 2016 Q3 | 15.26 Million USD | -76.96% |
| 2016 Q2 | 66.24 Million USD | -6.25% |
| 2016 Q1 | 70.65 Million USD | 2.59% |
| 2016 FY | -16.48 Million USD | -123.93% |
| 2016 Q4 | -16.48 Million USD | -207.97% |
| 2015 Q3 | 69.43 Million USD | 3337.06% |
| 2015 Q1 | 68.07 Million USD | 683.92% |
| 2015 FY | 68.87 Million USD | 690.75% |
| 2015 Q4 | 68.87 Million USD | -0.81% |
| 2015 Q2 | -2.14 Million USD | -103.15% |
| 2014 Q1 | 44.54 Million USD | 371.24% |
| 2014 FY | -11.65 Million USD | 29.0% |
| 2014 Q4 | -11.65 Million USD | -119.93% |
| 2014 Q3 | 58.49 Million USD | 1.13% |
| 2014 Q2 | 57.83 Million USD | 29.85% |
| 2013 Q3 | -13.67 Million USD | -11.69% |
| 2013 FY | -16.42 Million USD | 20.06% |
| 2013 Q2 | -12.23 Million USD | 32.07% |
| 2013 Q1 | -18.01 Million USD | 12.29% |
| 2013 Q4 | -16.42 Million USD | -20.12% |
| 2012 Q3 | 11.81 Million USD | 155.56% |
| 2012 Q4 | -20.54 Million USD | -273.93% |
| 2012 FY | -20.54 Million USD | -26.25% |
| 2012 Q1 | 13.44 Million USD | 78.48% |
| 2012 Q2 | -21.25 Million USD | -258.13% |
| 2011 Q4 | 7.53 Million USD | 138.43% |
| 2011 FY | -16.27 Million USD | 24.18% |
| 2011 Q1 | 12.2 Million USD | 10.82% |
| 2011 Q2 | -20.79 Million USD | -270.39% |
| 2011 Q3 | -19.6 Million USD | 5.76% |
| 2010 Q2 | -28.38 Million USD | -217.56% |
| 2010 FY | -21.46 Million USD | -538.5% |
| 2010 Q1 | 24.14 Million USD | 19.12% |
| 2010 Q4 | 11.01 Million USD | 177.22% |
| 2010 Q3 | 3.97 Million USD | 114.0% |
| 2009 Q1 | 19.31 Million USD | 87.8% |
| 2009 Q4 | 20.27 Million USD | 26.54% |
| 2009 Q3 | 16.01 Million USD | 204.75% |
| 2009 FY | -3.36 Million USD | 79.26% |
| 2009 Q2 | -15.29 Million USD | -179.19% |
| 2008 FY | -16.2 Million USD | 15.29% |
| 2008 Q4 | 10.28 Million USD | 56.38% |
| 2008 Q3 | 6.57 Million USD | 666.32% |
| 2008 Q2 | 858 Thousand USD | 106.18% |
| 2008 Q1 | -13.88 Million USD | 27.42% |
| 2007 Q3 | -26.07 Million USD | -1454.7% |
| 2007 FY | -19.13 Million USD | -122.23% |
| 2007 Q1 | -604 Thousand USD | 92.98% |
| 2007 Q2 | 1.92 Million USD | 418.71% |
| 2007 Q4 | -19.13 Million USD | 26.64% |
| 2006 Q1 | 12.86 Million USD | 77.37% |
| 2006 FY | -8.6 Million USD | -218.73% |
| 2006 Q2 | -17.49 Million USD | -236.05% |
| 2006 Q3 | -14.44 Million USD | 17.42% |
| 2006 Q4 | -8.6 Million USD | 40.42% |
| 2005 FY | 7.25 Million USD | 81.91% |
| 2005 Q4 | 7.25 Million USD | 0.0% |
| 2004 Q4 | 3.98 Million USD | 0.0% |
| 2004 FY | 3.98 Million USD | 0.0% |
| 2002 FY | 187 Thousand USD | 119.13% |
| 2001 FY | -977.3 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -1084.215% |
| BrainsWay Ltd. | -10.32 Million USD | 3207.645% |
| Cerus Corporation | 84.35 Million USD | -280.203% |
| Envoy Medical, Inc. | -3.81 Million USD | 8508.731% |
| electroCore, Inc. | -9.95 Million USD | 3321.587% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 6357.737% |
| IceCure Medical Ltd | -9.93 Million USD | 3328.397% |
| Inogen, Inc. | -103.56 Million USD | 409.657% |
| OrthoPediatrics Corp. | -9.26 Million USD | 3560.764% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 8908.267% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 2548.714% |
| MaxCyte, Inc. | -27.76 Million USD | 1255.167% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 6341.79% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 55801.178% |
| Orthofix Medical Inc. | 96.44 Million USD | -232.541% |
| PAVmed Inc | 29.08 Million USD | -1002.623% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 1993.317% |
| RxSight, Inc. | -6.68 Million USD | 4901.033% |
| Sight Sciences, Inc. | -102.71 Million USD | 412.232% |
| SI-BONE, Inc. | 5.72 Million USD | -5505.821% |
| TELA Bio, Inc. | -3.94 Million USD | 8221.271% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -459.497% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -91010.511% |
| Acutus Medical, Inc. | 12.27 Million USD | -2511.849% |
| Talis Biomedical Corporation | -57.06 Million USD | 662.016% |
| Spectral AI, Inc. | -3.5 Million USD | 9260.497% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 767.768% |
| CVRx, Inc. | -59.95 Million USD | 634.907% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -16063.587% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -25001.731% |
| Bioventus Inc. | 372.51 Million USD | 13.906% |
| Venus Concept Inc. | 74.3 Million USD | -331.635% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 3249.764% |
| LivaNova PLC | 62.53 Million USD | -412.872% |
| 908 Devices Inc. | -115.09 Million USD | 378.645% |
| Nemaura Medical Inc. | 9.92 Million USD | -3131.32% |
| NeuroPace, Inc. | 54.33 Million USD | -490.222% |
| LENSAR, Inc. | -18.31 Million USD | 1851.36% |
| Apyx Medical Corporation | -5.15 Million USD | 6326.15% |
| Cutera, Inc. | 288.3 Million USD | -11.241% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -4167.585% |
| BioSig Technologies, Inc. | 262 Thousand USD | -122308.015% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 831.711% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 3586.346% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 77.178% |
| Axonics, Inc. | -77.19 Million USD | 515.458% |
| Outset Medical, Inc. | 67.67 Million USD | -373.868% |
| IRIDEX Corporation | -4.28 Million USD | 7579.221% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 280.155% |
| IRadimed Corporation | -47.71 Million USD | 772.076% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 10698.447% |
| INVO Bioscience, Inc. | 8.45 Million USD | -3694.862% |
| Telesis Bio, Inc. | 32.63 Million USD | -882.715% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 12917.429% |
| Varex Imaging Corporation | 316.9 Million USD | -1.202% |
| Quipt Home Medical Corp. | 81.73 Million USD | -292.379% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 11628.001% |
| Pulmonx Corporation | -42.36 Million USD | 857.103% |
| Dynatronics Corporation | 6.2 Million USD | -5069.363% |
| Modular Medical, Inc. | -8.04 Million USD | 4087.926% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 7563.556% |
| Semler Scientific, Inc. | -57.13 Million USD | 661.367% |
| InMode Ltd. | -135.39 Million USD | 336.871% |
| Bruker Corporation | 891.3 Million USD | 64.018% |
| Cytosorbents Corporation | 4.18 Million USD | -7568.767% |
| DexCom, Inc. | 2.02 Billion USD | 84.184% |
| Align Technology, Inc. | -840.47 Million USD | 138.158% |
| Viveve Medical, Inc. | -13.81 Million USD | 2421.791% |
| ZimVie Inc. | 450.41 Million USD | 28.798% |
| Movano Inc. | -5.86 Million USD | 5567.252% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 338.523% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 55801.178% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -16063.587% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 10.115% |
| Profound Medical Corp. | -18.17 Million USD | 1864.22% |
| Insulet Corporation | 798.1 Million USD | 59.816% |
| enVVeno Medical Corporation | -2.21 Million USD | 14559.378% |
| Surmodics, Inc. | -12.01 Million USD | 2769.461% |
| iCAD, Inc. | -21.2 Million USD | 1612.136% |
| Nuwellis, Inc. | -2.81 Million USD | 11476.694% |
| Biotricity, Inc. | 23.09 Million USD | -1288.788% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -242.451% |
| Aethlon Medical, Inc. | -4.5 Million USD | 7224.235% |
| InspireMD, Inc. | -8.04 Million USD | 4086.439% |
| PAVmed Inc. | 29.08 Million USD | -1002.623% |
| BIOLASE, Inc. | 11.34 Million USD | -2727.124% |
| Beyond Air, Inc. | 6.22 Million USD | -5048.643% |
| FONAR Corporation | -14.66 Million USD | 2286.852% |
| AxoGen, Inc. | 32.26 Million USD | -893.953% |
| Vivani Medical, Inc. | 42 Thousand USD | -763492.857% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 3109.092% |
| Inari Medical, Inc. | -7.16 Million USD | 4578.55% |
| UFP Technologies, Inc. | 40.77 Million USD | -686.553% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -10351.232% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 6821.613% |
| Tenon Medical, Inc. | -1.25 Million USD | 25654.502% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 4316.526% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 2789.088% |
| AdaptHealth Corp. | 2.21 Billion USD | 85.537% |
| Sintx Technologies, Inc. | 905 Thousand USD | -35337.459% |
| NanoVibronix, Inc. | -3.27 Million USD | 9883.679% |
| Quanterix Corporation | -132.95 Million USD | 341.211% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 11628.001% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 1533.977% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 57.45% |
| TransMedics Group, Inc. | 121.13 Million USD | -164.756% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 1325.015% |
| NeuroMetrix, Inc. | -1.49 Million USD | 21608.648% |
| Hyperfine, Inc. | -75.61 Million USD | 524.112% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | -110.731% |
| Biomerica, Inc. | -3.38 Million USD | 9574.417% |
| Bone Biologics Corporation | -3.02 Million USD | 10696.454% |
| AVITA Medical, Inc. | -26.23 Million USD | 1322.605% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 17544.902% |
| Silk Road Medical, Inc | 64.42 Million USD | -397.818% |